| Nome |
# |
|
Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review, file de2a638f-dd9b-8577-e053-3705fe0aa5f3
|
26
|
|
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial., file de2a638e-fe9e-8577-e053-3705fe0aa5f3
|
22
|
|
Localized muscle vibration in the treatment of motor impairment and spasticity in post-stroke patients: a systematic review, file de2a6390-aadd-8577-e053-3705fe0aa5f3
|
16
|
|
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective?, file de2a638e-fef3-8577-e053-3705fe0aa5f3
|
13
|
|
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy, file de2a638f-def4-8577-e053-3705fe0aa5f3
|
12
|
|
Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques., file de2a638f-02b9-8577-e053-3705fe0aa5f3
|
8
|
|
Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke., file de2a638e-ffba-8577-e053-3705fe0aa5f3
|
7
|
|
Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke, file de2a638f-d728-8577-e053-3705fe0aa5f3
|
7
|
|
Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?, file de2a638e-fd7a-8577-e053-3705fe0aa5f3
|
6
|
|
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease., file de2a638f-02b7-8577-e053-3705fe0aa5f3
|
6
|
|
Post-stroke spasticity as a condition: a new perspective on patient evaluation, file de2a638f-d4d5-8577-e053-3705fe0aa5f3
|
6
|
|
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial, file de2a638e-fd7f-8577-e053-3705fe0aa5f3
|
5
|
|
Does Spasticity Reduction by Botulinum Toxin Type A Improve Upper Limb Functionality in Adult Post-Stroke Patients? A Systematic Review of Relevant Studies., file de2a638f-02bb-8577-e053-3705fe0aa5f3
|
5
|
|
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward., file de2a638f-02d0-8577-e053-3705fe0aa5f3
|
5
|
|
Influence of physician empathy on the outcome of botulinum toxin treatment for upper limb spasticity in patients with chronic stroke: A cohort study, file de2a638f-d551-8577-e053-3705fe0aa5f3
|
5
|
|
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease., file de2a6390-8295-8577-e053-3705fe0aa5f3
|
5
|
|
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease., file de2a638e-fd77-8577-e053-3705fe0aa5f3
|
4
|
|
Anti-β-Amyloid Immunotherapy forAlzheimer's Disease: Focus on Bapineuzumab., file de2a638e-fd78-8577-e053-3705fe0aa5f3
|
4
|
|
Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke., file de2a638e-fd7b-8577-e053-3705fe0aa5f3
|
4
|
|
Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty., file de2a638e-fd7c-8577-e053-3705fe0aa5f3
|
4
|
|
Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies., file de2a638e-fef5-8577-e053-3705fe0aa5f3
|
4
|
|
Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation., file de2a638e-fef6-8577-e053-3705fe0aa5f3
|
4
|
|
Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors., file de2a638f-02af-8577-e053-3705fe0aa5f3
|
4
|
|
Vitamin D serum level in subjects with critical illness polyneuropathy and myopathy, file de2a6390-702b-8577-e053-3705fe0aa5f3
|
3
|
|
Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms., file de2a6390-91d8-8577-e053-3705fe0aa5f3
|
3
|
|
Is the outcome of diagnostic nerve block related to spastic muscle echo intensity? A retrospective observational study on patients with spastic equinovarus foot, file 179a43b6-e93b-4de7-9cfa-21d7bf5927e8
|
2
|
|
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus?, file de2a638e-f5cc-8577-e053-3705fe0aa5f3
|
2
|
|
Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus?, file de2a638e-fd80-8577-e053-3705fe0aa5f3
|
2
|
|
Current epidemiological approaches to the metabolic-cognitive syndrome., file de2a638e-ffd1-8577-e053-3705fe0aa5f3
|
2
|
|
Parkinson's Disease: New Insights into Pathophysiology and Rehabilitative Approaches, file de2a638f-6077-8577-e053-3705fe0aa5f3
|
2
|
|
Postural and balance disorders in patients with Parkinson's disease: A prospective open-label feasibility study with two months of action observation treatment, file de2a638f-607d-8577-e053-3705fe0aa5f3
|
2
|
|
Ultrasonographic evaluation of botulinum toxin injection site for the medial approach to tibialis posterior muscle in chronic stroke patients with spastic equinovarus foot: An observational study, file de2a6390-0889-8577-e053-3705fe0aa5f3
|
2
|
|
Combined effects of isokinetic training and botulinum toxin type a on spastic equinus foot in patients with chronic stroke: A pilot, single-blind, randomized controlled trial, file de2a6390-6cd6-8577-e053-3705fe0aa5f3
|
2
|
|
Lifestyle-related factors, alcohol consumption, and mild cognitive impairment, file de2a6390-8538-8577-e053-3705fe0aa5f3
|
2
|
|
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms., file de2a6390-8756-8577-e053-3705fe0aa5f3
|
2
|
|
Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment. The Italian Longitudinal Study on Aging, file de2a6390-9982-8577-e053-3705fe0aa5f3
|
2
|
|
Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke, file 4fa63dfd-fbfc-401b-be07-9786a775fe72
|
1
|
|
Late-life depression, mild cognitive impairment, and dementia: possible continuum?, file de2a638e-fb01-8577-e053-3705fe0aa5f3
|
1
|
|
Lifestyle-related factors in predementia and dementia syndromes., file de2a638e-fd8e-8577-e053-3705fe0aa5f3
|
1
|
|
Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study., file de2a638f-0115-8577-e053-3705fe0aa5f3
|
1
|
|
Extracorporeal shock wave therapy for the treatment of poststroke plantar-flexor muscles spasticity: a prospective open-label study., file de2a638f-02d4-8577-e053-3705fe0aa5f3
|
1
|
|
Safety and efficacy of incobotulinumtoxin A as a potential treatment for poststroke spasticity, file de2a638f-607a-8577-e053-3705fe0aa5f3
|
1
|
|
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?, file de2a638f-6910-8577-e053-3705fe0aa5f3
|
1
|
|
Effects of Robot-Assisted Training for the Unaffected Arm in Patients with Hemiparetic Cerebral Palsy: A Proof-of-Concept Pilot Study, file de2a6390-0250-8577-e053-3705fe0aa5f3
|
1
|
|
Iatrogenic nerve lesion following laparoscopic surgery. A case report, file de2a6390-21d9-8577-e053-3705fe0aa5f3
|
1
|
|
AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study., file de2a6390-69c7-8577-e053-3705fe0aa5f3
|
1
|
|
Electrical stimulation of antagonist muscles after botulinum toxin type A for post-stroke spastic equinus foot. A randomized single-blind pilot study, file de2a6390-6fc2-8577-e053-3705fe0aa5f3
|
1
|
|
Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach†, file de2a6390-7023-8577-e053-3705fe0aa5f3
|
1
|
|
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease., file de2a6390-829d-8577-e053-3705fe0aa5f3
|
1
|
|
Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia?, file de2a6390-84b6-8577-e053-3705fe0aa5f3
|
1
|
|
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease, file de2a6390-875d-8577-e053-3705fe0aa5f3
|
1
|
|
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes, file de2a6390-87c4-8577-e053-3705fe0aa5f3
|
1
|
|
Change of diagnoses in probable and possible mild cognitive impairment: the Italian Longitudinal Study on Aging, file de2a6390-887c-8577-e053-3705fe0aa5f3
|
1
|
|
Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure., file de2a6390-8968-8577-e053-3705fe0aa5f3
|
1
|
|
Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity, file de2a6390-ae17-8577-e053-3705fe0aa5f3
|
1
|
|
Rectus femoris characteristics in post stroke spasticity: Clinical implications from ultrasonographic evaluation, file de2a6390-c565-8577-e053-3705fe0aa5f3
|
1
|
|
Triceps surae muscle characteristics in spastic hemiparetic stroke survivors treated with botulinum toxin type a: Clinical implications from ultrasonographic evaluation, file de2a6391-153a-8577-e053-3705fe0aa5f3
|
1
|
|
Suspension of Care for Patients With Spasticity During COVID-19 Pandemic: Ethical and Medico-Legal Point of View Starting From an Italian Study, file de2a6391-1793-8577-e053-3705fe0aa5f3
|
1
|
|
Early botulinum toxin type a injection for post-stroke spasticity: A longitudinal cohort study, file de2a6391-1a43-8577-e053-3705fe0aa5f3
|
1
|
|
Focal neuropathy mimicking focal dystonia in a child: Diagnostic and rehabilitative tools, file de2a6391-1a45-8577-e053-3705fe0aa5f3
|
1
|
|
Transcranial Direct Current Stimulation Combined with Botulinum Neurotoxin Type A Injections for Treatment of Upper Limb Intention Tremor in Multiple Sclerosis: A Case Report, file de2a6391-1aee-8577-e053-3705fe0aa5f3
|
1
|
|
High dosage of botulinum toxin type a in adult subjects with spasticity following acquired central nervous system damage: Where are we at?, file de2a6391-1bea-8577-e053-3705fe0aa5f3
|
1
|
| Totale |
236 |